Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marconi

Showing results (351-360 of 393) with videos related to

Pageof 40
Sort By:
Health and Quality of Life Outcomes|August 22, 2023
Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in AfricaTamlyn A Rautenberg, Shu Kay Ng, Gavin George, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2017
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-DimerBarbara S Taylor, Kaku So-Armah, Janet P Tate, et al.
American Journal of Epidemiology|March 16, 2023
Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision MedicineMichael Jetsupphasuk, Michael G Hudgens, Haidong Lu, et al.
Clinical and Translational Medicine|March 12, 2025
Aberrant DNA methylation of genes regulating CD4+ T cell HIV-1 reservoir in women with HIVKe Xu, Xinyu Zhang, Kesava Asam, et al.
Open Forum Infectious Diseases|July 12, 2022
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2023
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine RolloutAlexandra N Lea, Wendy A Leyden, Oleg Sofrygin, et al.
Progress in Cardiovascular Diseases|February 19, 2020
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis CKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
JAMA|January 3, 2023
Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the USLauren C Zalla, Stephen R Cole, Joseph J Eron, et al.
The Journal of Infectious Diseases|November 24, 2023
Associations Between HIV and Severe Mpox in an Atlanta CohortBruce Aldred, Jane Y Scott, Amalia Aldredge, et al.
Open Forum Infectious Diseases|July 20, 2023
Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIVMolly L Hirsh, Jonathan A Edwards, Chad Robichaux, et al.
Pageof 40

Showing results (351-360 of 393) with videos related to

Sort By:
Pageof 40
Health and Quality of Life Outcomes|August 22, 2023
Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in AfricaTamlyn A Rautenberg, Shu Kay Ng, Gavin George, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2017
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-DimerBarbara S Taylor, Kaku So-Armah, Janet P Tate, et al.
American Journal of Epidemiology|March 16, 2023
Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision MedicineMichael Jetsupphasuk, Michael G Hudgens, Haidong Lu, et al.
Clinical and Translational Medicine|March 12, 2025
Aberrant DNA methylation of genes regulating CD4+ T cell HIV-1 reservoir in women with HIVKe Xu, Xinyu Zhang, Kesava Asam, et al.
Open Forum Infectious Diseases|July 12, 2022
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2023
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine RolloutAlexandra N Lea, Wendy A Leyden, Oleg Sofrygin, et al.
Progress in Cardiovascular Diseases|February 19, 2020
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis CKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
JAMA|January 3, 2023
Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the USLauren C Zalla, Stephen R Cole, Joseph J Eron, et al.
The Journal of Infectious Diseases|November 24, 2023
Associations Between HIV and Severe Mpox in an Atlanta CohortBruce Aldred, Jane Y Scott, Amalia Aldredge, et al.
Open Forum Infectious Diseases|July 20, 2023
Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIVMolly L Hirsh, Jonathan A Edwards, Chad Robichaux, et al.
Pageof 40